+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-opioid Pain Patches Market - Global Forecast 2026-2032- Product Image
Non-opioid Pain Patches Market - Global Forecast 2026-2032- Product Image
Sale

Non-opioid Pain Patches Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460257
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-opioid Pain Patches Market is projected to reach USD 1.02 Billion in 2026. It is expected to continue growing at a CAGR of 13.22%, reaching USD 2.14 Billion by 2032.

Non-opioid pain patches are moving from a niche topical therapy category into a strategic pain-management segment as clinicians, payers, and consumers prioritize localized analgesia with lower systemic exposure than many oral medicines. The category spans prescription lidocaine patches, capsaicin systems, topical NSAID patches where approved, and over-the-counter counterirritant products using ingredients such as menthol, methyl salicylate, and capsaicin.

Demand is supported by the documented global burden of musculoskeletal disorders, neuropathic pain, sports injuries, arthritis-related pain, and back pain, alongside public-health efforts to reduce unnecessary opioid exposure. Regulatory oversight by agencies such as the U.S. FDA, EMA-aligned European authorities, and national drug regulators continues to shape product claims, safety labeling, manufacturing quality, and market access. For industry participants, growth depends on evidence-backed efficacy, skin tolerability, adhesive performance, drug-release consistency, and clear differentiation between prescription therapeutics and consumer self-care products.

Transformative Shifts Reshaping the Pain Patch Landscape

The non-opioid pain patches landscape is being reshaped by the convergence of opioid stewardship, self-care adoption, aging populations, and advances in transdermal delivery. Clinical guidelines increasingly favor multimodal pain management, and topical therapies are valued when pain is localized and patients seek options that may reduce gastrointestinal, hepatic, or systemic adverse-event concerns associated with some oral therapies.

Manufacturers are also competing on formulation science rather than ingredient familiarity alone. Improvements in pressure-sensitive adhesives, permeation enhancers, hydrogel matrices, and controlled-release designs are helping brands address wear time, residue, odor, heat sensitivity, and patient comfort. Retail pharmacy, e-commerce, and telehealth-enabled care pathways are expanding access, while regulators continue to scrutinize drug-device combination characteristics, labeling substantiation, pharmacovigilance, and quality systems.

Cumulative Impact of Artificial Intelligence on Non-Opioid Pain Patches

Artificial intelligence is beginning to influence the non-opioid pain patches value chain by improving formulation design, clinical evidence generation, supply planning, and safety monitoring. Machine learning can help screen excipient combinations, model skin permeation, predict adhesive behavior under humidity and movement, and optimize patch geometry for specific anatomical sites.

AI-enabled analytics also support pharmacovigilance by detecting adverse-event signals related to skin irritation, allergic reactions, misuse, heat exposure, or off-label application patterns across structured and unstructured data sources. In commercial operations, predictive models can improve inventory planning across retail and hospital channels, identify unmet needs among chronic pain populations, and support personalized education. The cumulative impact is not a replacement for clinical validation; rather, AI can shorten iteration cycles and strengthen data-backed decisions when governed by transparent, compliant quality frameworks.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-potential region for non-opioid pain patches due to large patient populations, rising healthcare access, rapid pharmacy retail expansion, and strong manufacturing ecosystems in countries such as China, India, Japan, South Korea, and Australia. The region also reflects increasing demand for convenient topical analgesic patches among aging populations, active consumers, and patients managing musculoskeletal pain. North America remains a leading environment for evidence-based topical analgesics, supported by opioid-reduction initiatives, strong OTC retail penetration, active sports medicine demand, and established regulatory pathways for prescription and nonprescription products.

Latin America shows growing uptake as urban pharmacies, private healthcare networks, and consumer self-care trends expand, with Brazil and Mexico acting as important demand centers for affordable and branded topical pain relief. Europe benefits from mature reimbursement discussions, aging demographics, and strict safety, labeling, and pharmacovigilance expectations under national and EU-aligned frameworks. The Middle East is gaining traction through modernizing healthcare infrastructure, high private-sector participation in GCC markets, and demand for convenient pain-relief formats, while Africa remains an emerging opportunity shaped by affordability, distribution reach, healthcare access gaps, and the need for trusted OTC products in fragmented retail environments.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO Markets

ASEAN markets are becoming increasingly relevant as rising disposable income, pharmacy modernization, medical tourism, and regional harmonization efforts support broader access to topical pain relief. The GCC benefits from high healthcare spending, expanding private hospitals, and a consumer base receptive to branded self-care products, although import dependence, halal considerations, and regulatory registration timelines remain important commercialization factors.

The European Union emphasizes quality, pharmacovigilance, ingredient substantiation, sustainability, and product-safety documentation, creating opportunities for compliant and clinically differentiated non-opioid pain patches. BRICS economies combine large patient pools with growing domestic manufacturing capabilities, expanding pharmacy networks, and price-sensitive access models. G7 markets generally lead in regulatory maturity, premium product positioning, clinical evidence requirements, and post-market safety expectations, while NATO-linked markets overlap with many advanced healthcare systems where defense readiness, workforce rehabilitation, sports medicine, and musculoskeletal care reinforce demand for non-opioid pain-management options.

Key Country Insights Covering Major Non-Opioid Pain Patch Markets

The United States is defined by opioid stewardship, strong retail pharmacy channels, sports medicine utilization, and FDA oversight for OTC and prescription topical analgesics, while Canada combines public-health caution on opioids with stable pharmacy distribution, provincial access considerations, and bilingual labeling requirements. Mexico and Brazil are important Latin American markets where affordability, branded generics, pharmacy chains, and retail access influence adoption of non-opioid pain patches for back pain, arthritis-related pain, and minor musculoskeletal injuries.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show demand linked to aging populations, sports injuries, arthritis, occupational strain, and chronic back pain, with national reimbursement, pharmacy classification, and advertising rules shaping uptake; Russia remains a distinct market influenced by local registration, supply-chain resilience, domestic sourcing priorities, and price sensitivity. In Asia-Pacific, China and India offer scale, manufacturing advantages, and expanding consumer healthcare channels; Japan has a sophisticated transdermal and aging-care environment; South Korea supports innovation through advanced healthcare infrastructure and high digital-health adoption; and Australia combines strong OTC governance with demand for active-lifestyle pain relief and pharmacist-guided self-care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically supported product differentiation, including validated wear time, predictable drug release, low irritation potential, strong adhesion, and clear indication-specific claims. Companies that invest in real-world evidence, human factors testing, stability data, dermatologic safety evaluation, and patient adherence insights can strengthen trust with clinicians, retailers, regulators, and consumers.

Commercial teams should segment the market by pain type, channel, ingredient class, and regulatory status rather than treating all patches as interchangeable. Strategic actions include building pharmacy education programs, improving e-commerce content compliance, partnering with sports medicine and rehabilitation providers, diversifying supply sources for adhesives and active ingredients, and using AI-driven planning to reduce stockouts. Sustainability should also be integrated through responsible packaging, solvent management, waste reduction, and quality-by-design manufacturing practices.

Research Methodology

This executive summary is developed using a structured secondary-research methodology aligned with market-intelligence best practices. Inputs include publicly available regulatory guidance, drug labeling frameworks, clinical guideline trends, pharmacovigilance principles, healthcare access indicators, demographic patterns, pain-management literature, and documented shifts in self-care and opioid stewardship.

The analysis triangulates insights across product type, active ingredient class, distribution channel, regional regulation, and end-user behavior. Emphasis is placed on verified, data-backed themes rather than unsupported market-size, market-share, or forecasting claims.

Conclusion

Non-opioid pain patches are positioned to play a larger role in modern pain management as healthcare systems seek practical alternatives that support localized relief, patient convenience, and opioid-risk reduction. The market’s strongest opportunities will emerge where clinical evidence, regulatory compliance, formulation performance, patient comfort, and accessible distribution intersect.

Companies that combine robust science with patient-centered design, AI-enabled operations, and region-specific commercialization strategies will be best placed to compete. As adoption expands across mature and emerging markets, the winners will be those that demonstrate safety, efficacy, affordability, labeling integrity, and trust across the full product life cycle.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-opioid Pain Patches Market, by Patch Type
7.1. Introduction
7.2. Lidocaine Patches
7.3. Diclofenac Patches
7.4. Capsaicin Patches
7.5. Methyl Salicylate Patches
7.6. Ketoprofen Patches
7.7. Menthol Patches
8. Non-opioid Pain Patches Market, by Technology
8.1. Introduction
8.2. Matrix Patches
8.3. Reservoir Patches
8.4. Drug-in-Adhesive Patches
8.5. Microneedle-Enhanced Patches
9. Non-opioid Pain Patches Market, by Application
9.1. Introduction
9.2. Acute Pain
9.2.1. Postoperative Pain
9.2.2. Sports Injury Pain
9.3. Chronic Pain
9.3.1. Arthritis
9.3.2. Neuropathic Pain
10. Non-opioid Pain Patches Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Non-opioid Pain Patches Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Non-opioid Pain Patches Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Non-opioid Pain Patches Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Non-opioid Pain Patches Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AdhexPharma SAS
16.2. Altergon Italia S.r.l.
16.3. Amneal Pharmaceuticals, Inc.
16.4. Bayer AG
16.5. Beiersdorf AG
16.6. Cipla Limited
16.7. Endo International plc
16.8. GlaxoSmithKline plc
16.9. Grünenthal GmbH
16.10. Hisamitsu Pharmaceutical Co., Inc.
16.11. IBSA Institut Biochimique SA
16.12. Johnson & Johnson Services, Inc.
16.13. Mentholatum Company, Inc.
16.14. Novartis AG
16.15. Perrigo Company plc
16.16. Pfizer Inc.
16.17. Sanofi
16.18. Sun Pharmaceutical Industries Limited
16.19. Teikoku Seiyaku Co., Ltd.
16.20. Teva Pharmaceutical Industries Ltd.
16.21. Viatris Inc.
16.22. Zhejiang Hisun Pharmaceutical Co., Ltd.
16.23. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NON-OPIOID PAIN PATCHES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MENTHOL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MENTHOL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MENTHOL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MATRIX PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MATRIX PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MATRIX PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ACUTE PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ACUTE PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ACUTE PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ARTHRITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ARTHRITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ARTHRITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 105. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 107. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 108. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 110. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 111. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 113. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 123. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 125. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 128. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 129. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 131. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 135. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 136. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 137. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 138. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 139. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 141. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 142. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 144. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 145. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 146. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 147. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 148. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 150. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 160. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 162. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 165. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 166. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 168. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 169. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 171. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 174. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 175. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 177. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 178. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 180. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 183. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 184. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 186. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 197. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 199. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 202. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 203. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 205. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 206. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 208. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 211. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 212. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 214. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 235. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 238. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 239. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 241. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 242. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 244. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 247. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 248. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 250. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 260. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 262. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 265. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 266. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 268. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 269. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 271. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 274. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 275. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 277. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 278. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 280. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 283. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 284. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 286. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 287. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 289. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 291. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 292. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 293. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 295. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 298. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 301. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 302. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 304. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 313. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 324. GLOBAL NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • AdhexPharma SAS
  • Altergon Italia S.r.l.
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • Beiersdorf AG
  • Cipla Limited
  • Endo International plc
  • GlaxoSmithKline plc
  • Grünenthal GmbH
  • Hisamitsu Pharmaceutical Co., Inc.
  • IBSA Institut Biochimique SA
  • Johnson & Johnson Services, Inc.
  • Mentholatum Company, Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.02 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.14 Billion
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Non-opioid Pain Patch - Global Strategic Business Report - Product Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • 483 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2026 - Product Image

Non-Opioid Pain Patch Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Non-opioid Pain Patch Market Outlook 2026-2034: Market Share and Growth Analysis by Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patch Types), Technology, Indication, Distribution Channel - Product Image

Non-opioid Pain Patch Market Outlook 2026-2034: Market Share and Growth Analysis by Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patch Types), Technology, Indication, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Non-Opioid Pain Treatment Market Report 2026 - Product Image

Non-Opioid Pain Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.